Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study in Pancreatic Allograft Recipients: The Effect of Risk Factors, Immunosuppressive Level and the Benefits of Scheduled Biopsies - on Surgical Complications, Rejections and Graft Survival

NCT01957696 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01957696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01957696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study in Pancreatic Allograft Recipients: The Effect of Risk Factors, Immunosuppressive Level and the Benefits of Scheduled Biopsies - on Surgical Complications, Rejections and Graft Survival
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 30, 2013
Completion date
October 31, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allograft biopsies, allograft rejection, diabetes mellitus, pancreas transplantation, surgical complication nec